Results 221 to 230 of about 144,032 (247)

Broad-spectrum antiviral activity of antisense oligonucleotides targeting GBF1 against SARS-CoV-2 and influenza viruses. [PDF]

iScience
Simanihuruk V, Kida Y, Takada K, Yamaguma H, Kameoka N, Anzai I, Shichinohe S, Obika S, Kasahara Y, Watanabe T.   +9 more
europepmc   +1 more source

Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1. [PDF]

Am J Hum Genet
González-Martínez I, Cerro-Herreros E, Carrascosa-Sàez M, García-Rey A, Piqueras-Losilla D, Colom-Rodrigo A, Moreno N, Chakraborty M, Huguet-Lachon A, González-Barriga A, Naldaiz-Gastesi N, Dehesa M, Díaz-Maqueda A, Barquero N, Varela MA, López de Munain A, Eritja R, Gourdon G, López-Castel A, Pérez-Alonso M, Llamusi B, Artero R.   +21 more
europepmc   +1 more source

Telomerase as a therapeutic Bullseye: advances in cancer treatment and clinical trials : A comprehensive review of small molecule inhibitors, antisense oligonucleotides, and immunotherapeutic strategies targeting the telomerase catalytic subunit (hTERT). [PDF]

Biol Res
Hussain A, Abbas M, Long M, Mustafa G, Yasir HM, Abbas T, Raza Y, Lateef M, Shoaib M, Ul Abideen Z, Shah W.   +10 more
europepmc   +1 more source

OpenASO: RNA Rescue-designing splice-modulating antisense oligonucleotides through community science. [PDF]

RNA
Tse V, Guiterrez M, Townley J, Romano J, Pearl J, Pearl J, Chacaltana G, Players E, Das R, Sanford JR, Stone MD.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides

Nucleic Acids Research, 2021
Eric E Swayze, Xue-Hai Liang, Punit P Seth   +2 more
exaly  

Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases

Neuron, 2017
Kathleen Schoch, Timothy M Miller
exaly  

RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform

Annual Review of Pharmacology and Toxicology, 2010
Eric E Swayze, C Frank Bennett
exaly